Attitudes and practices in the management of attention deficit hyperactivity disorder among Brazilian pediatric neurologists who responded to a national survey: a cross-sectional study.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Author(s): Nunes MEN;Nunes MEN; Zuanetti PA; Zuanetti PA; Hamad APA; Hamad APA
  • Source:
    Sao Paulo medical journal = Revista paulista de medicina [Sao Paulo Med J] 2022 Dec 19; Vol. 141 (4), pp. e2021966. Date of Electronic Publication: 2022 Dec 19 (Print Publication: 2022).
  • Publication Type:
    Journal Article
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Associação Paulista de Medicina Country of Publication: Brazil NLM ID: 100897261 Publication Model: eCollection Cited Medium: Internet ISSN: 1806-9460 (Electronic) Linking ISSN: 15163180 NLM ISO Abbreviation: Sao Paulo Med J Subsets: MEDLINE
    • Publication Information:
      Original Publication: São Paulo, S.P., Brazil : Associação Paulista de Medicina, [1994-
    • Subject Terms:
      Attention Deficit Disorder with Hyperactivity*/diagnosis ; Attention Deficit Disorder with Hyperactivity*/drug therapy ; Methylphenidate*/adverse effects ; Central Nervous System Stimulants*/therapeutic use; Child ; Adolescent ; Humans ; Cross-Sectional Studies ; Neurologists ; Brazil ; Attitude
    • Abstract:
      Background: Attention deficit hyperactivity disorder (ADHD) has a prevalence of 5.3% among children and adolescents. It is characterized by attention deficit, hyperactivity, and impulsivity.
      Objective: We aimed to conduct a survey involving pediatric neurologists in the management of ADHD and compare the results with the current literature and guidelines.
      Design and Setting: Descriptive analytical study of a virtual environment, was used Test of equality of proportions for comparison between two groups of pediatric neurologists (working as specialists for > 6 versus ≤ 6 years), with a significance level of P = 0.05.
      Methods: This cross-sectional study used a virtual questionnaire covering the steps in the diagnosis and treatment of children with ADHD. The inclusion criteria were professionals who had completed their residency/specialization in pediatric neurology and clinical neurologists working in pediatric neurology.
      Results: Among the 548 electronic invitations sent, 128 were considered valid. For all participants, the diagnosis was clinically based on the disease classification manuals. Combination treatment promotes improvement of symptoms (96.9%). Among psychostimulants, short-acting methylphenidate was the most commonly prescribed medication (85.2%). Headache was the most common side effect (77.3%). Altogether, 73.4% of the participants requested laboratory tests, 71.1% requested an electrocardiogram, and 42.2% requested an electroencephalogram. Pediatric neurologists working as specialists for ≤ 6 years had more frequent referrals to psycho-pedagogists for diagnosis (P = 0.03).
      Conclusions: The participants complied with clinical guidelines, emphasizing the relevance of diagnostic manuals and treatment guidelines for an eminently clinical situation and enabling uniformity in quality treatment.
    • References:
      Arch Pediatr Adolesc Med. 2003 Jan;157(1):17-25. (PMID: 12517190)
      Am J Psychiatry. 2007 Jun;164(6):942-8. (PMID: 17541055)
      N Engl J Med. 2014 Feb 27;370(9):838-46. (PMID: 24571756)
      Psychiatr Clin North Am. 2010 Sep;33(3):497-509. (PMID: 20599129)
      Cardiol Young. 2016 Jan;26(1):216-9. (PMID: 26278960)
      Wiley Interdiscip Rev Cogn Sci. 2015 Jan;6(1):39-52. (PMID: 25558298)
      Epilepsy Behav. 2007 May;10(3):384-8. (PMID: 17368109)
      J Child Psychol Psychiatry. 2013 Mar;54(3):227-46. (PMID: 23294014)
      Psychiatr Clin North Am. 2004 Jun;27(2):373-83. (PMID: 15064003)
      J Am Acad Child Adolesc Psychiatry. 2006 Nov;45(11):1284-1293. (PMID: 17023867)
      Am J Epidemiol. 2010 Dec 1;172(11):1292-8. (PMID: 20880962)
      BMC Psychiatry. 2013 Sep 27;13:237. (PMID: 24074240)
      Nat Rev Dis Primers. 2015 Aug 06;1:15020. (PMID: 27189265)
      J Clin Child Adolesc Psychol. 2018 Mar-Apr;47(2):157-198. (PMID: 29257898)
      Cleve Clin J Med. 2015 Nov;82(11 Suppl 1):S2-7. (PMID: 26555810)
      Pharmacol Biochem Behav. 2011 Aug;99(2):262-74. (PMID: 21596055)
      Paediatr Drugs. 2010 Jun;12(3):165-75. (PMID: 20481646)
      Pediatrics. 2019 Oct;144(4):. (PMID: 31570648)
      Ann Pharmacother. 2014 Feb;48(2):209-25. (PMID: 24259638)
      Essent Psychopharmacol. 2005;6(5):262-76. (PMID: 16222911)
      J Pediatr (Rio J). 2004 Apr;80(2 Suppl):S61-70. (PMID: 15154074)
      Child Adolesc Psychiatr Clin N Am. 2014 Oct;23(4):825-42. (PMID: 25220089)
      CNS Drugs. 2004;18(14):1011-30. (PMID: 15584770)
      Pediatr Neurol. 2001 Feb;24(2):99-102. (PMID: 11275457)
      J Pediatr. 1997 Jan;130(1):40-4. (PMID: 9003849)
      J Environ Manage. 2009 Jan;90(1):284-92. (PMID: 18082316)
      J Child Neurol. 2009 Jun;24(6):727-33. (PMID: 19491115)
      J Child Neurol. 2003 Feb;18(2):109-12. (PMID: 12693777)
      Neuropharmacology. 2009 Dec;57(7-8):579-89. (PMID: 19627998)
      Lancet. 2016 Mar 19;387(10024):1240-50. (PMID: 26386541)
      J Am Acad Child Adolesc Psychiatry. 2007 Jul;46(7):894-921. (PMID: 17581453)
      CNS Drugs. 2008;22(3):213-37. (PMID: 18278977)
      Pharmacotherapy. 2009 Jun;29(6):656-79. (PMID: 19476419)
      Ir J Psychol Med. 2014 Mar;31(1):31-37. (PMID: 30189470)
      J Am Acad Child Adolesc Psychiatry. 1997 Oct;36(10 Suppl):85S-121S. (PMID: 9334567)
      Cochrane Database Syst Rev. 2009 Jul 08;(3):MR000008. (PMID: 19588449)
    • Accession Number:
      207ZZ9QZ49 (Methylphenidate)
      0 (Central Nervous System Stimulants)
    • Publication Date:
      Date Created: 20221221 Date Completed: 20230403 Latest Revision: 20230406
    • Publication Date:
      20230406
    • Accession Number:
      PMC10065098
    • Accession Number:
      10.1590/1516-3180.2021.0966.R1.20092022
    • Accession Number:
      36541950